Relación costo-efectividad de la vacuna contra Haemophilus influenzae tipo b en niños menores de dos años de edad en Colombia

Guzmán, Nelson Alvis; De La Hoz Restrepo, Fernando; Consuelo, David Vivas.
Rev Panam Salud Publica ; 20(4),oct. 2006 tab, graf
Artículo | PAHOIRIS | ID: phr-7920

Documentos relacionados

  1. Cross-reactivity of Haemophilus influenzae type a and b polysaccharides: molecular modeling and conjugate immunogenicity studies.
  2. Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use.
  3. National and provincial impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis.
  4. A multi-enzyme machine polymerizes the Haemophilus influenzae type b capsule.
  5. Invasive Haemophilus influenzae type b infection in a patient with transient hypogammaglobulinemia of infancy.
  6. 50 Years Ago in TheJournalofPediatrics: Important Observations on the Way to Development of Haemophilus influenzae Type b Vaccine.
  7. SEROPROTECTION RATE OF HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE AND ASSOCIATED CLINICAL OUTCOMES AMONG NIGERIAN CHILDREN AGED 6 TO 23 MONTHS.
  8. Racial Disparities in Invasive Haemophilus influenzae Disease-United States, 2008-2017.
  9. 50 Years Ago in TheJournalofPediatrics: Susceptibility to Haemophilus influenzae Type b: Lessons from the Past, for the Future.
  10. Laboratory surveillance of invasive Haemophilus influenzae disease in Argentina, 2011-2019.